John Catanzaro, MD, chief of the division of cardiology and director of cardiology services at ECU Health, performed the procedure with Elutia’s EluPro device at the East Carolina University Health Medical Center, according to a Sept. 5 news release from the biotechnology company.
The device, cleared by the FDA in June, slowly releases antibiotics and stimulates tissue regeneration.
“EluPro is designed to prevent postoperative complications in patients with cardiac implantable devices such as pacemakers and internal defibrillators,” the release said. “It is also approved for use with additional devices, including neuromodulators and neurostimulators for pain management, epilepsy, incontinence and sleep apnea.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
